Decitabine mildly attenuates MLL ‐rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo‐sensitizer-Reference-Cited by-同舟云学术

Decitabine mildly attenuates MLL ‐rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo‐sensitizer

Published:2020-08-24 Issue:2 Volume:1 Page:527-536
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Schneider Pauline¹^ORCID,Castro Patricia Garrido¹,Pinhanços Sandra M.¹,Kerstjens Mark²,Roon Eddy H.²,Essing Anke H.W.¹,Dolman M. Emmy M.¹,Molenaar Jan J.¹,Pieters Rob¹,Stam Ronald W.¹

Affiliation:

1. Princess Máxima Center for Pediatric Oncology Utrecht The Netherlands

2. Department of Pediatric Hematology/Oncology Erasmus MC ‐ Sophia Children's Hospital Rotterdam The Netherlands

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jha2.81

Reference47 articles.

1. Acute Lymphoblastic Leukemia in Children

2. Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study

3. A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial

4. Unravelling the cellular origin and clinical prognostic markers of infant B‐cell acute lymphoblastic leukemia using genome‐wide analysis;Agraz‐Doblas A;Haematologica,2019

5. The landscape of somatic mutations in infant MLL-rearranged acute lymphoblastic leukemias

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Evaluation of Stable Long Circulating Decitabine-loaded Copolymeric Nanoparticles: Harnessing QbD Approach and Lyophilization Technique;Journal of Pharmaceutical Innovation;2024-06

3. Bone Marrow Microenvironment-Induced Chemoprotection in KMT2A Rearranged Pediatric AML Is Overcome by Azacitidine–Panobinostat Combination;Cancers;2023-06-08

4. Updates in KMT2A Gene Rearrangement in Pediatric Acute Lymphoblastic Leukemia;Biomedicines;2023-03-08

5. In the Pipeline—Emerging Therapy for ALL;Pathogenesis and Treatment of Leukemia;2023